摘要
Analyses of DNA methylation in human cancers have identified hypermethylation of individual genes and diminished methylation at repeat elements as common alterations,and have thereby provided important mechanistic insights into cancer biology as well as biomarkers for cancer detection,prognosis and prediction of therapy responses.The techniques available in the past were best suited for investigations of individual candidate genes and sequences,whereas recently developed high-throughput techniques promise to generate unbiased and comprehensive surveys of DNA methylation states across entire genomes.In this minireview we give a short overview of established and novel techniques and outline some major questions that can now be addressed to develop further cancer biomarkers and therapies based on DNA methylation.
